-+ 0.00%
-+ 0.00%
-+ 0.00%

US Food and Drug Administration: Boston Scientific Enroute NPS initiated a recall due to head end separation risk.

智通財經·08/26/2026 15:01:13
語音播報
US Food and Drug Administration: Boston Scientific Enroute NPS initiated a recall due to head end separation risk.